This inventor holds 1 USPTO granted patent. Top assignees: Marine Biological Laboratory, The University of Texas System, University of California. Active years: 2021.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:



Years Active: 2021
Title: David J Busch: Innovator in Spinal Cord and Brain Injury Treatment
Introduction
David J Busch is a notable inventor based in Manor, TX (US). He has made significant contributions to the field of medical treatment, particularly in addressing spinal cord injuries and traumatic brain injuries. His innovative approach focuses on the inhibition of synuclein protein aggregation, which is crucial for improving patient outcomes.
Latest Patents
David J Busch holds a patent for the treatment of spinal cord injury or traumatic brain injury by inhibition of synuclein protein aggregation. The patent outlines methods that include the use of molecular tweezers and nucleobase oligomers capable of inhibiting the accumulation or aggregation of amyloidogenic proteins and synuclein proteins. These treatments may enhance the results of spinal cord surgery or traumatic brain injury, promoting neuronal survival, regeneration, and recovery of neuronal functions. He has 1 patent to his name.
Career Highlights
Throughout his career, David has worked with esteemed institutions such as the University of Texas System and the Marine Biological Laboratory. His work has been pivotal in advancing the understanding and treatment of neurological injuries.
Collaborations
David has collaborated with notable colleagues, including Gal Bitan and Jennifer R Morgan. Their combined expertise has contributed to the development of innovative treatment methods in the field.
Conclusion
David J Busch's work in the treatment of spinal cord and brain injuries showcases his dedication to improving medical outcomes through innovation. His contributions are vital in the ongoing quest to enhance recovery for individuals affected by these serious conditions.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile